SPX3,825.33+39.95 1.06%
DIA310.85+3.03 0.98%
IXIC11,127.85+99.11 0.90%

Wedbush Lifts Price Target on Global Blood Therapeutics to $74 From $73 on Oxbryta Estimates, Keeps Outperform Rating

MT Newswires · 06/13/2022 02:58

Please log in to view news